Frequent high expression of bax pro-apoptotic protein in non-small cell lung cancer

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 825-827

  Caputi, Mario ^a   Groeger, Angela M ^b,c   Esposito, Vincenzo ^a,c   De Luca, Antonio ^c   Murabito, Marco ^b   Tahir, Tario ^b   Giordano, Giovan Giacomo ^a   Baldi, Feliciano ^a   Giordano, Antonio ^c   Wolner, Ernst ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF VIENNA   (Austria)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bax; Immunohistochemistry; Non small cell lung cancer

Indexed keywords

PROTEIN BAX;

ADULT; APOPTOSIS; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYTOPLASM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032923254     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
2. Kroemer G, Petit PX, Zamzami N, Vayssiere JL, Mignotte B: The biochemistry of apoptosis. Faseb J 9: 1277-1287, 1995.
3. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620, 1997.
4. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Path 145: 1323-1336, 1994.
5. Zhan O, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJ Jr: Induction of bax by genotoxic stress in human cells correlates with normal pS3 status and apoptosis. Oncogene 9: 3743-3751, 1994.
6. Sang N, Baldi A, Giordano A: The roles of tumor suppressors pRb and p53 in cell proliferation and cancer. Mol Cell Diff 3(1): 1-29, 1995.
7. World Health Organization: Histological typing of lung tumors. 2nd ed., Geneva pp. 25-26, 1981.
8. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ: Lung. In: Manual for staging of cancer. 4th ed. Chicago, American Joint Committee on Cancer pp.115-122, 1992.
9. Craig RW: The Bcl-2 gene family. Cancer Biol 6: 35-43, 1995.
10. Reeve JG, Xiong J, Morgan J, Blechen NM: Expression of apoptosisregulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. Br J Cancer 73: 1193-1200, 1996.
11. Apolinario RM, van der Valk P, de Jong JS, Deville W, van Ark-Otte J, Dingemans AM, van Mourik JC, Postmus PE, Pinedo HM, Giaccone G: Prognostic value of the expression of p53, bcl-2 and bax oncoproteins, and neovascularization in patients with radically resected non small cell lung cancer. J Clin Oncol 15: 2456-2466, 1997.